ESG

Environmental, Social, and Governance (ESG)

What We Do

As a pioneering investor focused on global healthcare with a strong transpacific commercial strategy and proven track record in growth and innovation, we are uniquely well-placed to drive positive change through our portfolio companies and our own operations.

Our ESG Values

We have established a set of ESG values, which help inform LYFE’s approach to investing policies, processes and goals.

We see ESG performance as a vital measure to mitigate risks and create long-term value for portfolio companies, the environment and society as a whole.

Our ESG strategy is proportionate, and tailored to the varying levels of access to information and influence which exist across different deals.

Where appropriate and possible, we do not exclude companies from investment purely on the grounds of lack of ESG awareness. Instead, we adopt a positive engagement approach, seeking to improve their ESG performance through management and collaboration.

Environment

At LYFE, we seek to build long-term value while reducing the impact of our own operations and our portfolio companies on the planet.

We selected an energy-efficient building for our new office in Singapore and also promote the use of virtual meetings over business travel. We encourage our employees to use public transport when commuting to work and have established targets at all LYFE locations to minimize bottled water consumption. These steps help us to reduce operational expenses and support the firm to grow sustainably.

When it comes to investment decisions, we integrate climate-related factors into our due diligence process.

We also assess the pollution emission controls and environmental protection measures implemented by our portfolio companies, on an ongoing basis. All portfolio companies comply with applicable environmental protection standards, ensuring adherence to regulatory requirements and best practices. The information we collect includes data on each company’s annual energy and water consumption, the percentage of waste they recycle, reuse or divert to landfill, and details about their net zero targets.

Case Study

Fong's Engineering & Manufacturing

Fong’s Engineering & Manufacturing, a portfolio company in which we acquired a supermajority stake in 2023, has taken several measures to improve its environmental performance since then.

Headquartered in Singapore, the precision engineering company designs, manufactures and repairs products across a range of sectors, primarily for the medical industry.

In 2024, Fong’s implemented practices and technologies to minimize waste, reuse materials throughout its operations, and assess the environmental impact of products and services throughout their lifecycle – including raw materials.

Fong’s has committed to switching to cleaner fuels wherever possible, and is providing employees with training about air pollution control. The company has also introduced solar power generation, resulting in a 10% reduction in its carbon emissions.

Social

We believe that an inclusive work environment allows our employees to thrive, in turn improving innovation and productivity. Within LYFE’s own operations we invest in employee development, encouraging our people to fulfil their potential and help the firm maintain its competitive advantage.

Our team comprises professionals from a wealth of diverse backgrounds, and 35% of LYFE employees are women. Women also account for 25% of our investment team, and 25% of our front and back-office managers. We advocate for equality throughout the hiring process and there have been no reported incidents (0 cases) related to diversity & inclusion or discrimination across the firm’s operations, reflecting our commitment to fostering an inclusive and equitable workplace.

Across our portfolio companies, women currently hold up to 62% of management positions, reflecting our support for gender diversity in business.

On an annual basis, we gather data from our portfolio companies focusing on their approach to inclusion. As part of this, we ask for information about the number of women in senior roles, the number of employees from ethnic minority backgrounds, and any employee engagement scores gathered by the company.

Case Study

Meitheal

Drug shortages are becoming growing concerns for patients in US, esp. during COVID, while high price of drugs are burdening public health. Meitheal dedicated itself to address shortages of essential injectables for patients and ease public health burdens with lower price in US. With LYFE Capital’s investment, Meitheal was able to rapidly grow to meet its strategic goals. A total of 143K COVID patients in ICU were free from muscle relaxant shortage; $516M healthcare cost savings from lower-priced drugs.

Governance

Across our business – on both sides of the Pacific – we maintain a flat organizational structure. We invite open communication and we link pay to performance with a transparent and fair compensation structure.

All LYFE staff receive ESG training as part of the onboarding process, and all employees receive regular training on our Code of Ethics. We are proud to maintain a record of zero incidents involving corruption, bribery or unethical practices.

Additional ESG and Compliance training is provided on a yearly basis, and all employees are familiar with our policies and procedures around ESG and operational Compliance.

Case Study

Recbio

Founded in 2012, Jiangsu Recbio Technology Co Ltd (Recbio) develops best-in-class vaccines with exclusive rights. Recbio has more than 10 potential blockbuster vaccines designed to help protect against cervical cancer, RSV infection and a range of other prevalent diseases.

Recbio’s Board of Directors is responsible for the governance of its ESG-related strategies, objectives and policies, and members hold regular meetings to review risks and opportunities.

The company’s ESG Working Group, led by investors (including representatives from Lyfe) and Recbio’s Public Relations team, maintains good communication with stakeholders, determining material annual ESG issues, and reporting to the Board on a regular basis. On an operational basis, each functional department within Recbio is responsible for implementing various ESG matters and sharing the progress of ESG work.

Recbio has established a ‘three committees and the management’ governance model, consisting of the general meeting, the Board of Directors, the Supervisory Committee and the management. It has also established an Audit Committee, a Remuneration & Appraisal Committee and a Nomination Committee under the Board. Each plays a key role in assisting decision making, safeguarding the scientific and forward-looking nature of the company, and facilitating excellent corporate governance.